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In peripheral blood and lymphoid tissues of primates, 
there are 2 major types of dendritic cells (DCs), myeloid 
DCs (mDCs) and plasmacytoid DCs (pDCs), identifiable 
by mutually exclusive expression of the cell-surface in-
tegrin CD11c, and the IL-3Rα chain CD123, respectively 
[1]. pDCs, also referred to as natural-interferon-produc-
ing cells, respond to microbial pathogens by rapidly 
producing interferon (IFN)–α, as well as other proin-
flammatory cytokines such as interleukin-12 (IL-12) and 
tumor necrosis factor (TNF)–α, initiating a cascade of 
both innate and adaptive immune responses. Although 
pDCs have been primarily characterized in periph-
eral blood samples, multiple studies have revealed that 
pDCs develop in the bone marrow or the thymus and 
then emigrate to numerous lymphoid and nonlymphoid 
tissues under steady-state conditions [2]. However, at 
present, very little is known about pDCs in human tis-
sues other than blood and lymph nodes, in part due to 
limited access to tissue samples. 
As first reported over a decade ago, multiple groups 
have verified that pDC numbers are severely reduced 
in blood and lymph nodes during human immunode-
ficiency virus (HIV) infection [3]. Furthermore, loss of 
pDCs begins during primary infection, is associated 
with increasing viral loads, and is only partially revers-
ible by highly active antiretroviral therapy. Although 
pDCs do harbor infectious virus, infection rates are rel-
atively low, suggesting the loss of pDCs from blood 
and lymph nodes is likely dependent on factors besides 
direct infection. A comparable loss of pDCs has been 
demonstrated in simian immunodeficiency virus (SIV)–
infected macaques [4]. Studies of acute pathogenic len-
tivirus infection in macaques have demonstrated a tran-
sient increase of pDCs in peripheral blood due to rapid 
egress from the bone marrow, followed by rapid de-
pletion of circulating pDCs and the death of pDCs in 
lymph nodes [4, 5]. However, in a nonpathogenic len-
tiviral model, acute SIVagm infection of African green 
monkeys resulted in a transient reduction of pDCs in 
blood associated with an accumulation in the lymph 
nodes [6]. Multiple studies have also suggested cyto-
kine production by pDCs is impaired in HIV/SIV in-
fection. While this is a generally accepted phenomenon, 
subsequent research indicates that much of the per-
ceived pDC dysfunction ex vivo is likely to reflect over-
stimulation in vivo [7]. Furthermore, although pDCs 
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Abstract
Multiple studies suggest that plasmacytoid dendritic cells (pDCs) are depleted and dysfunctional during human immunodefi-
ciency virus/simian immunodeficiency virus (HIV/SIV) infection, but little is known about pDCs in the gut—the primary site of vi-
rus replication. Here, we show that during SIV infection, pDCs were reduced 3-fold in the circulation and significantly upregu-
lated the gut-homing marker α4β7, but were increased 4-fold in rectal biopsies of infected compared to naive macaques. These 
data revise the understanding of pDC immunobiology during SIV infection, indicating that pDCs are not necessarily depleted, 
but instead may traffic to and accumulate in the gut mucosa. 
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have been described in the gastrointestinal tract, and 
despite the dramatic effects of HIV/SIV infection on 
pDCs in the blood, little is known about the effects of 
pDCs in the gastrointestinal mucosa, the primary site of 
virus replication. 
METHODS
Animals
Twenty-five Indian rhesus macaques (Macaca mulatta) 
were analyzed: 15 SIV-naive macaques and 10 ma-
caques infected chronically with SIVmac239. All ani-
mals were free of simian retrovirus type D, simian T-
lymphotrophic virus type 1, and herpes B virus, and 
were housed at the New England Primate Research 
Center and maintained in accordance with the guide-
lines of the Committee on Animals of the Harvard 
Medical School and the Guide for the Care and Use of 
Laboratory Animals. 
Cell Processing
Macaque peripheral blood mononuclear cells were iso-
lated from ethylenediaminetetraacetic acid (EDTA)–
treated blood by density gradient centrifugation over 
lymphocyte separation medium (MP Biomedicals, So-
lon, OH) and contaminating red blood cells were lysed 
using a hypotonic ammonium chloride solution. Rec-
tal biopsies were collected using 1.9 mm fenestrated 
endoscopic biopsy forceps (Olympus America, Cen-
ter Valley, PA). Biopsy pieces and/or colonic tissue sec-
tions were weighed in bulk (Mettler balances MS104S or 
PB602, Mettler-Toledo, Columbus, OH), then mononu-
clear cells were isolated by both enzymatic and mechan-
ical disruption as described previously [8]. 
Polychromatic Flow Cytometry and Fluorescent Bead-
Based Cell Quantification
Flow cytometry staining of mucosal mononuclear cells 
was carried out for cell-surface and intracellular mole-
cules using standard protocols and the monoclonal anti-
bodies noted in Table 1 [9]. LIVE/DEAD Aqua dye (Invit-
rogen, Carlsbad, CA) and isotype-matched controls and/
or fluorescence-minus-one controls were included in all 
assays. All acquisitions were made on an LSR II flow cy-
tometer (BD Biosciences, La Jolla, CA) and analyzed us-
ing FlowJo software (Tree Star Inc., Ashland, OR). Abso-
lute quantification of cell subsets in blood and mucosal 
biopsy samples was performed using polychromatic flow 
cytometry gating strategies previously described [4, 8, 9] 
and shown in Figure 1A in combination with fluorescent 
bead-based assays optimized in our laboratory [8, 10]. 
Intracellular Cytokine Staining
Mucosal mononuclear cells were resuspended in Ro-
swell Park Memorial Institute medium 1640 (Sigma-Al-
drich, St. Louis, MO) containing 10% fetal bovine serum 
alone or with imiquimod (Sigma-Aldrich) at a final con-
centration of 10 μM. GolgiPlug (brefeldin A) and Golgi-
Stop (monensin) were added at final concentrations of 
6 µg/mL to all samples and then cultured for 12 hours 
at 37°C in 5% CO2. After culture, samples were sur-
face-stained using markers to delineate pDCs as shown 
in Figure 1. Cells were permeabilized using Caltag Fix 
and Perm, and intracellular cytokine staining was per-
formed for macrophage inflammatory protein (MIP)–1β 
(fluorescein isothiocyanate conjugate, clone 24006, R&D 
Systems), IFN-α (phycoerythrin conjugate, clone 225.C, 
Chromaprobe, Maryland Heights, MO) and TNF-α (Al-
exa 700 conjugate, Mab11). 
Table 1. Antibodies Used in Polychromatic Flow Cytometry Analyses
Antibody Clone Fluorochrome Manufacturer
anti-α4β7 A4B7 APC NIH NPRRa
anti-CD3 SP34.2 APC-Cy7 BD Biosciences (La Jolla, CA)
anti-CD11c S-HCL3 PE, APC BD Biosciences
anti-CD14 M5E2 Alexa700, PE-Cy7 BD Biosciences
anti-CD16 3G8 FITC BD Biosciences
anti-CD20 L27 PerCp-Cy5.5 BD Biosciences
anti-CD45 D058-1283 Pacific Blueb BD Biosciences
anti-CD123 7G3 PE, PE-Cy7 BD Biosciences
anti-HLA-DR Immu-357 PE-Texas Red Beckman-Coulter
anti-IFN-α2 225.C PE Chromaprobe (Maryland Heights, MO)
anti-MIP-1β 24006 FITC R&D Systems (Minneapolis, MN)
anti-TNF-α MAb11 Alexa700 BD Biosciences
Abbreviations: HLA-DR, human leukocyte antigen–DR; IFN, interferon; MIP, macrophage inflammatory protein; TNF, tumor necrosis factor. 
a NIH Nonhuman Primate Reagent Resource. 
b In-house custom conjugate. 
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Plasma Virus Load Quantification
RNA copy equivalents were determined in EDTA-
treated plasma using a quantitative real-time reverse-
transcription polymerase chain reaction assay based on 
amplification of conserved sequences in gag [11]. The 
limit of detection for this assay was 30 viral RNA copy 
equivalents/mL plasma. 
Immunohistochemistry and Confocal Microscopy  
for pDCs In Situ
Identification and quantification of CD123+ cells by im-
munohistochemistry was performed as described pre-
viously [12]. Briefly, immunochemically stained whole 
tissue sections were scanned using Scanscope. A dig-
ital slide of each CD123 stain was opened in ImageS-
cope and laminar propria areas were selected with Im-
ageScope drawing tools for analysis. CD123+ cells were 
quantified by using a positive pixel count algorithm in 
the Spectrum Plus analysis program (version 9.1). The 
parameters of the algorithm were manually tuned to 
match the CD123+ markup image accurately over back-
ground DAB stain. Once the parameters were set, the al-
gorithm was applied automatically to all digital slides to 
measure the number of CD123+ cells. 
Confocal microscopy on colorectal sections was per-
formed as previously described [13]. Briefly, tissue sec-
tions were stained with primary antibodies to CD123 
and human leukocyte antigen (HLA)–DR, and then sec-
ondary antibodies labeled with Alexa Fluor 488 (green) 
and Alexa Fluor 555 (red), respectively. Cell nuclei were 
counterstained blue with TOTO-3. Sequential images at 
wavelengths for each fluorophore were collected using 
a Bio-Rad MRC 1000 Confocal Microscope at ×60 and 
were processed in Adobe Photoshop 7.0. 
Figure 1. Dendritic cell dynamics in blood and colorectal mucosae of naive and SIV-infected macaques. A, Representative gating strategy for 
pDCs and mDCs. B, Absolute numbers of pDCs and mDCs in peripheral blood and colorectal biopsies were enumerated using a bead-nor-
malized flow cytometry assay [8]. Black horizontal lines indicate medians. C, MFIs of cell-surface expressed α4β7 on peripheral blood pDCs 
and mDCs. Bars represent means ± SEM of 9 animals per group. D, Plasma viral loads were correlated with absolute numbers of blood pDCs 
(upper panel) and cell-surface expression of α4β7 on blood pDCs (middle panel). Mann–Whitney U tests were used for naive-versus-SIV com-
parisons and Spearman correlation tests were used to assess associations with plasma viral loads. *P < .05; **P < .001. 
Abbreviations: FSC-A, forward-scatter area; HLA-DR, human leukocyte antigen–DR; mDCs, myeloid dendritic cells; MFIs, median fluores-
cence intensities; Mono., monocyte; pDCs, plasmacytoid dendritic cells; SIV, simian immunodeficiency virus.
SIV Infection Induces Accumulation of Plasmacytoid Dendritic Cells in the Gut Mucosa   1465
Statistical Analyses
All statistical analyses were performed using GraphPad 
Prism 5.0 software (GraphPad Software Inc, La Jolla, 
CA). Nonparametric Mann-Whitney and Spearman cor-
relation tests and unpaired t tests were used where in-
dicated and P < .05 were assumed to be significant in all 
analyses. 
RESULTS
During Chronic SIV Infection, pDCs Are Reduced in Periph-
eral Blood but Accumulate in the Gut Mucosa
We first identified pDCs and mDCs among live CD45+ 
mononuclear cells that were HLA-DR+ and negative for 
common lineage markers (CD3, CD14, CD20) and found 
them easily distinguishable in both blood and rectal mu-
cosa by mutually exclusive expression of CD123 and 
CD11c (Figure 1A). Next, we applied our 8-color flow 
cytometry panel to fluorescent bead quantification as-
says optimized in our laboratory for both blood and 
rectal biopsies to quantify absolute numbers of pDCs 
and mDCs in chronically SIV-infected and naive rhe-
sus macaques (Figure 1B). These analyses revealed no 
change in absolute numbers of circulating mDCs, but 
a significant reduction of circulating pDCs in chroni-
cally infected animals (P = .0005), similar to previously 
published observations [4, 5]. However, in colorectal bi-
opsies, pDC numbers were increased 4-fold in SIV-in-
fected animals, while no change was observed in abso-
lute counts of mDCs. Interestingly, the pDCs that did 
remain in peripheral blood of infected animals had sig-
nificantly higher levels of cell-surface α4β7, a MAD-
CAM-1-binding integrin, which has been previously 
shown to mediate trafficking and retention of T and 
natural killer (NK) cells in the gut mucosae [9, 14] (Fig-
ure 1C). In infected animals, both the loss of pDCs in 
the peripheral blood and the upregulation of α4β7 on 
blood pDCs were significantly related to plasma viral 
load (Figure 1D). However, neither blood pDC numbers 
nor plasma viral loads significantly correlated with pDC 
numbers in colorectal biopsies (data not shown). 
To further confirm our observations that pDCs accu-
mulate in the gut mucosae during SIV infection, we next 
performed immunohistochemistry analysis of CD123+ 
Figure 2. Gut mucosal pDCs in situ. A, Representative immunohistochemistry slides of pDCs (stained brown) in colorectal tissue from naive 
(left panel) and chronically SIV-infected macaques (right panel). B, Quantitative analysis of gut mucosal pDC in naive (n = 3) and SIV-infected 
(n = 5) macaques. Total CD123+ cells were calculated per mm2 as described in the “Methods” section. The Mann–Whitney U test was used 
to evaluate significance; *P < .05. C, Immunofluorescent images of CD123 (green) colocalizing with HLA-DR (red) on the surface of pDCs in 
colorectal tissue. Cell nuclei are counterstained in blue. 
Abbreviations: HLA-DR, human leukocyte antigen–DR; SIV, simian immunodeficiency virus.
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cells. These studies verified that pDCs were significantly 
increased in colorectal specimens of SIV-infected ma-
caques and showed that most CD123+ cells were found 
in the lamina propria (Figure 2A and 2B). Using confo-
cal microscopy, we also demonstrated that the vast ma-
jority of colorectal CD123+ lymphocytes were HLA-DR+, 
further confirming their identity as pDCs (Figure 2C). 
Gut pDCs from Naive and SIV-Infected Macaques Are Po-
tent Cytokine-Producing Cells
Many previous studies have suggested that during 
chronic HIV/SIV infection pDCs are dysfunctional. 
However, subsequent studies indicate that this perceived 
dysfunction is at least partially attributable to overstimu-
lation in vivo [7]. Furthermore, these studies did not ad-
dress pDCs in the mucosae. Using a 3-function intracel-
lular cytokine-staining assay, we sought to evaluate the 
functional capacity of colonic pDCs. Because pDCs are 
relatively rare in the gut mucosa, for functional assays we 
used mononuclear cells isolated from colons taken at nec-
ropsy from naive and SIV-infected macaques. Not sur-
prisingly, relatively high frequencies of pDCs were pos-
itive for IFN-α secretion even without stimulation, and 
production was significantly enhanced by addition of the 
Toll-like receptor 7 ligand imiquimod (Figure 3). How-
ever, IFN-α production in response to imiquimod stim-
ulation was significantly less in pDCs from infected an-
imals, suggesting some refractoriness to stimulation. 
Interestingly, high frequencies of colonic pDCs were also 
positive for MIP-1β production, a C-C chemokine recep-
tor type 5 (CCR5) β-chemokine known to block HIV/SIV 
infection [15], but produced only low levels of the proin-
flammatory cytokine TNF-α. 
DISCUSSION
Here, we present data indicating that the currently ac-
cepted pathogenesis of systemic pDC depletion during 
lentivirus infection is, at least in part, inaccurate. While 
many studies of both HIV-infected humans and SIV-in-
fected macaques indicate pDCs are depleted in periph-
eral blood and lymph nodes, these studies have not ana-
lyzed pDCs in the gut mucosa, the primary site of virus 
replication. We present here, alternatively, that while 
pDC numbers are diminished in the blood of chroni-
cally SIV-infected macaques, they are accumulating in 
the gut mucosa. 
Similar to what has been previously observed in both 
HIV and SIV infections [3, 4], we found reduced num-
bers of pDCs in the circulation of chronically SIV-in-
fected macaques, which negatively correlated with vi-
ral load. However, most previously published results 
have reported decreased frequencies of pDCs, and we 
verify here for the first time a loss of absolute numbers 
of pDCs as determined by a more accurate bead-based 
Figure 3. Mucosal pDC function. A, Representative flow cytometry plots showing percentages of colonic pDCs (as gated in Figure 1) expressing 
intracellular cytokines with and without stimulation. B, Percentages of colonic pDCs from naive and SIV-infected macaques positive for intra-
cellular IFN-α, MIP1-β and TNF-α, without stimulation (media) and with imiquimod added to cultures. Bars represent means ± SEM of 4 animals 
per group. Unpaired t tests were used for naive-versus-SIV comparisons; *P < .05. Only statistically significant differences are shown. 
Abbreviations: FMO, fluorescence minus one; IFN, interferon; mDCs, myeloid dendritic cells; MIP, macrophage inflammatory protein; pDCs, 
plasmacytoid dendritic cells; SIV, simian immunodeficiency virus; TNF, tumor necrosis factor.
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enumeration assay. Next, we observed in these same 
animals increased numbers of pDCs in colorectal biop-
sies from infected animals, also determined by a highly 
sensitive bead-based enumeration assay [8]. These data 
suggested that as pDCs are reduced in blood, they accu-
mulate in the gastrointestinal tract—a hypothesis sup-
ported by mouse studies showing that pDCs accumu-
late in tissues where there is active viral replication due 
to the many strategies pDCs have evolved to “sense” vi-
ral products [16]. 
To explore potential mechanisms of trafficking, we 
next evaluated expression of the gut-trafficking and re-
tention integrin α4β7 on blood pDCs. In infected ani-
mals, α4β7 was significantly upregulated, correlating 
with increasing viral load. While not definitive, these 
data suggest increased α4β7 expression on pDCs as a 
plausible mechanism for increased trafficking and re-
tention of these cells in the gastrointestinal mucosa, a 
phenomenon also observed with T and NK cells dur-
ing chronic lentivirus infections [9, 14]. While increased 
α4β7 expression appears to be related to increased 
pDCs in the gut, the exact mechanisms responsible for 
this altered trafficking repertoire remain unclear. It 
could reflect upregulation of α4β7 on previously α4β7 
-negative differentiated pDCs by retinoic acid imprint-
ing as has been observed for T cells [14], or alterna-
tively an emigration of α4β7+ pDCs from a currently 
undefined reservoir. 
Previous studies have reported that blood pDCs are 
functionally impaired during HIV and SIV infection. 
Similarly, we found a modest, but significant, reduc-
tion in IFN-α production by mucosal pDCs from SIV-
infected macaques. However, it is difficult to deter-
mine from these analyses whether pDCs from infected 
animals are truly dysfunctional in IFN-α production, 
or if this reflects the fact that pDCs are overstimulated 
in vivo and therefore have reduced IFN-α–produc-
ing capacity ex vivo. This phenomenon has been pre-
viously described to account, in part, for reduced cy-
tokine production by blood pDCs from HIV-infected 
patients [7]. Regardless, the 4-fold increase in abso-
lute numbers of pDCs in the gut mucosa suggests that 
overall IFN-α production is likely to be increased, and 
we have previously found that in many infected ma-
caques, IFN-α is upregulated in the gut mucosa [17]. 
Although there may be multiple sources of IFN-α in 
the SIV-infected gut, pDCs could contribute to both 
IFN-α–induced chronic immune activation and IFN-α–
dependent cell apoptosis that have been described in 
chronic lentivirus infection [18]. Furthermore, these 
data indicate that pDCs in both naive and infected an-
imals are a potent source of MIP-1β. An overall in-
crease of MIP-1β in the gut during infection could po-
tentially have both beneficial and detrimental effects. 
First, β-chemokines such as MIP-1β have been previ-
ously shown to inhibit HIV/SIV infection by blocking 
the CCR5 coreceptor [15]. Alternatively, however, pDC 
secretion of MIP-1β could also recruit CCR5+ memory 
CD4+ T cells, the primary HIV/SIV target cells, to the 
gut, thereby fueling virus replication. A similar mecha-
nism of pDC-dependent recruitment of memory CD4+ 
T cells to the vaginal tract during transmission has re-
cently been proposed [15]. 
In summary, these data advance our understanding 
of pDC immunobiology during lentivirus infection by 
revising the current dogma that they are depleted and 
suggesting instead that they accumulate in the gut mu-
cosa. Given the complex network of virus-sensing mech-
anisms found in pDCs, in retrospect it is perhaps not 
surprising that these cells accumulate in the primary site 
of virus replication. However, the consequences of accu-
mulating pDCs in the gut mucosae in regard to chronic 
immune activation, cell apoptosis, and target cell re-
cruitment will require further study. 
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